These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15723103)

  • 21. Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients.
    Baskaran ND; Gan GG; Adeeba K
    Ann Hematol; 2008 Jul; 87(7):563-9. PubMed ID: 18437382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chemotherapy-induced febrile neutropenia: about 200 episodes. Clinical, microbiological and therapeutic characteristics].
    Gharbi O; Ben Hadj Hassen S; Kaabia N; Limam S; Hadj Amor M; Ben Fatma L; Landolsi A; Hochlef M; Letaief A; Boukadida J; Ben Ahmed S
    Pathol Biol (Paris); 2008 May; 56(3):154-7. PubMed ID: 18178025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low prevalence of complications in severe neutropenic children with cancer in the unprotected environment of an overnight camp.
    Tabori U; Jones H; Malkin D
    Pediatr Blood Cancer; 2007 Feb; 48(2):148-51. PubMed ID: 16421908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-risk febrile neutropenia in Auckland 2003-2004: the influence of the microbiology laboratory on patient treatment and the use of pathogen-specific therapy.
    Ritchie S; Palmer S; Ellis-Pegler R
    Intern Med J; 2007 Jan; 37(1):26-31. PubMed ID: 17199841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outpatient management of febrile neutropenia: time to revise the present treatment strategy.
    Carstensen M; Sørensen JB
    J Support Oncol; 2008; 6(5):199-208. PubMed ID: 18551855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk assessment and treatment of low-risk patients with febrile neutropenia.
    Kern WV
    Clin Infect Dis; 2006 Feb; 42(4):533-40. PubMed ID: 16421798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acute fever in an immunocompromised patient].
    Gallien S; Molina JM
    Rev Prat; 2007 Dec; 57(20):2297-304. PubMed ID: 18320753
    [No Abstract]   [Full Text] [Related]  

  • 28. Episodes of fever and neutropenia in children with cancer in a tertiary care medical center in Turkey.
    Tezcan G; Kupesiz A; Ozturk F; Ogunc D; Gultekin M; Yesilipek A; Hazar V
    Pediatr Hematol Oncol; 2006; 23(3):217-29. PubMed ID: 16517538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The evolution towards ambulatory and day-case management of febrile neutropenia.
    Chisholm JC; Dommett R
    Br J Haematol; 2006 Oct; 135(1):3-16. PubMed ID: 16925575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The feasibility of early hospital discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies.
    Cherif H; Johansson E; Björkholm M; Kalin M
    Haematologica; 2006 Feb; 91(2):215-22. PubMed ID: 16461306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognostic risk factors for serious complications in an inpatient population with neutropenia at the onset of a febrile episode].
    Gómez Roca C; Rivero M; Hugo K; Novillo A; Marta Lapadula M; Recondo G; Milberg M
    Medicina (B Aires); 2006; 66(5):385-91. PubMed ID: 17137166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating levels and promoter polymorphisms of interleukins-6 and 8 in pediatric cancer patients with fever and neutropenia.
    Lehrnbecher T; Fleischhack G; Hanisch M; Deinlein F; Simon A; Bernig T; Chanock SJ; Klingebiel T
    Haematologica; 2004 Feb; 89(2):234-6. PubMed ID: 15003900
    [No Abstract]   [Full Text] [Related]  

  • 33. Herpes simplex virus in febrile neutropenic children undergoing chemotherapy for cancer: a prospective cohort study.
    Ramphal R; Grant RM; Dzolganovski B; Constantin J; Tellier R; Allen U; Weitzman S; Matlow A; Petric M; Sung L
    Pediatr Infect Dis J; 2007 Aug; 26(8):700-4. PubMed ID: 17848881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients.
    Oude Nijhuis C; Kamps WA; Daenen SM; Gietema JA; van der Graaf WT; Groen HJ; Vellenga E; Ten Vergert EM; Vermeulen KM; de Vries-Hospers HG; de Bont ES
    J Clin Oncol; 2005 Oct; 23(30):7437-44. PubMed ID: 16234511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacterial infections in low-risk, febrile neutropenic patients.
    Kamana M; Escalante C; Mullen CA; Frisbee-Hume S; Rolston KV
    Cancer; 2005 Jul; 104(2):422-6. PubMed ID: 15937905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of febrile neutropenia in pediatric oncology patients: a Canadian survey.
    Boragina M; Patel H; Reiter S; Dougherty G
    Pediatr Blood Cancer; 2007 May; 48(5):521-6. PubMed ID: 16724314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colony-stimulating factors for chemotherapy-induced febrile neutropenia: a meta-analysis of randomized controlled trials.
    Clark OA; Lyman GH; Castro AA; Clark LG; Djulbegovic B
    J Clin Oncol; 2005 Jun; 23(18):4198-214. PubMed ID: 15961767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Strategies of treatment for febrile neutropenia].
    Terui Y
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):688-92. PubMed ID: 23863644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer-associated neutropenic fever: clinical outcome and economic costs of emergency department care.
    Courtney DM; Aldeen AZ; Gorman SM; Handler JA; Trifilio SM; Parada JP; Yarnold PR; Bennett CL
    Oncologist; 2007 Aug; 12(8):1019-26. PubMed ID: 17766662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunocompromised children with cancer.
    Mastrangelo R; Tornesello A; Mastrangelo S; Riccardi R
    Rays; 1994; 19(4):424-34. PubMed ID: 7871219
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.